Spotlight on Pfizer: Hedge Funds Shift Strategies in Latest 13F Filings
Recent filings reveal insights on how hedge funds are adjusting their positions in Pfizer Inc. (Symbol: PFE) as of September 30, 2024. Fourteen funds reported holdings, indicating a trend worth examining closely.
It is essential to note that 13F filings capture only the funds’ long positions, leaving out short positions which can skew the interpretation. For instance, a hedge fund may appear bullish by holding shares while simultaneously shorting the stock. This complexity means that while the filings give valuable information, they do not provide a complete picture of each fund’s strategy.
With that context in mind, observing trends within these filings can provide crucial insights. Let’s delve into the PFE positions from the latest 13F filers:
| Fund | New Position? | Change In Share Count | Change In Market Value ($ in 1000’s) |
|---|---|---|---|
| Palouse Capital Management Inc. | Existing | –2,746 | +$64 |
| Carolina Wealth Advisors LLC | NEW | +161 | +$5 |
| Northwest Investment Counselors LLC | NEW | +3,556 | +$103 |
| Livelsberger Financial Advisory | NEW | +4,278 | +$124 |
| Magnolia Capital Management Ltd. | Existing | UNCH | +$13 |
| Sequoia Financial Advisors LLC | Existing | +151,293 | +$4,639 |
| Kempner Capital Management Inc. | Existing | UNCH | +$102 |
| Flagship Harbor Advisors LLC | NEW | +63,815 | +$1,847 |
| Mattern Wealth Management LLC | Existing | UNCH | +$10 |
| Argus Investors Counsel Inc. | Existing | –11,300 | –$289 |
| Cetera Trust Company N.A | Existing | UNCH | +$2 |
| Vicus Capital | Existing | –800 | –$16 |
| Harbor Advisory Corp MA | Existing | +3,640 | +$223 |
| Traphagen Investment Advisors LLC | Existing | +323 | +$41 |
| Aggregate Change: | +212,220 | +$6,868 | |
Analyzing the change from June 30, 2024, to September 30, 2024, we see that three funds increased their PFE positions, three decreased their holdings, and four new positions were established.
Additionally, when looking at all funds that held PFE during the September 30, 2024 period (of the 1,382 total funds analyzed), we found an increase in aggregate holdings. Specifically, funds raised their total share count by 1,268,433 shares—from 81,278,561 to 82,546,994—an increase of about 1.56%. The top three funds showing the largest positions in PFE as of September 30, 2024, continue to command significant interest.
As we continue to track 13F filings, valuable patterns may emerge, revealing interesting investment stories across different fund managers. While individual filings may misrepresent a fund’s true stance, aggregated data across reporting periods can illuminate broader trends in a stock like Pfizer Inc. (Symbol: PFE).
10 S&P 500 Components Hedge Funds Are Buying »
Explore More:
• Cheap Midcap Stocks
• Top Ten Hedge Funds Holding BQR
• Top Ten Hedge Funds Holding FDC
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
